Histone deacetylases in cardiovascular and metabolic diseases

Area of Science:

• Epigenetics
• Molecular Biology
• Cardiovascular Science

Background:

• Histone deacetylases (HDACs) are crucial epigenetic regulators involved in gene transcription.
• HDACs play significant roles in cellular processes relevant to cardiovascular and metabolic diseases.
• Dysregulation of HDACs is linked to conditions such as cardiac hypertrophy, fibrosis, inflammation, and metabolic dysfunction.

Purpose of the Study:

• To investigate the multifaceted roles of HDACs in cardiovascular and metabolic diseases.
• To explore the therapeutic potential of targeting specific HDAC isoforms.

Main Methods:

• Utilized small molecule HDAC inhibitors for pharmacological intervention.
• Employed genetically modified mouse models (loss- and gain-of-function) to study specific HDAC isoforms.
• Examined HDAC involvement in cardiac hypertrophy, remodeling, fibrosis, calcium handling, inflammation, and energy metabolism.

Main Results:

• HDACs have been implicated in diverse pathological processes within cardiovascular and metabolic systems.
• Specific HDAC isoforms contribute to cardiac hypertrophy, fibrosis, inflammation, and metabolic dysregulation.
• Pharmacological and genetic approaches have elucidated isoform-specific functions.

Conclusions:

• HDACs are critical regulators in cardiovascular and metabolic health and disease.
• Isoform-selective HDAC inhibitors represent a promising therapeutic avenue for cardiovascular diseases, obesity, and diabetes.
• Targeted inhibition of specific HDACs holds potential for treating metabolic disorders and heart conditions.